VenoStent completes $20M Series A funding with $4M investment from Norwest Venture Partners to fund U.S. clinical trial and NIH SBIR grant
Amount Raised
$20 Million
Round Type
Series A
Investors
Description
VenoStent, Inc. closed an additional $4 million from Norwest Venture Partners to complete its Series A round at $20 million. The funding will be used to fund its U.S. clinical trial for a breakthrough medical device and to support its NIH SBIR Phase II Grant.
Quick answer
VenoStent raised $20 Million in a Series A round, dated June 27, 2024. Investors: IAG Capital Partners, Good Growth Capital and Norwest Venture Partners. VenoStent is based in Houston, Texas, United States.
- How much did VenoStent raise?
- VenoStent raised $20 Million in a Series A round on June 27, 2024.
- Who invested in VenoStent?
- IAG Capital Partners, Good Growth Capital and Norwest Venture Partners are named as investors in this round.
- What does VenoStent do?
- VenoStent is a venture backed, clinical stage medical device and tissue engineering company that’s developed bioabsorbable polymer scaffolds in order to vastly improve vascular surgery outcomes.
- Where is VenoStent based and how big is it?
- VenoStent is based in Houston, Texas, United States. Fundz records about 36 employees.
- Who are the decision-makers at VenoStent?
- Fundz holds 1 contact at VenoStent. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as VenoStent that raised within 45 days of this round, from Fundz verified event records.
- Hummingbird Healthcare raised $9.9M on May 29, 2024.
- Hummingbird Healthcare raised $1.1M on May 29, 2024.
- Eva Medtec raised $50K on August 10, 2024.
- InterShunt Technologies raised $18M on August 9, 2024.
- Tenax Therapeutics raised $100M on August 8, 2024.
- Indaptus Therapeutics, Inc. raised $205K (Pre-Seed) on August 7, 2024.
Who to call at VenoStent, and when
A new round usually means VenoStent is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day VenoStent raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VenoStent, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VenoStent. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VenoStent raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVenoStent raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.